![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
|
|
|
Reported by Jules Levin
EASL April 23-26 2009-04-30
Copenhagen, Denmark
D.R. Nelson, R.H. Ghalib, M. Sulkowski, E. Schiff, V. Rustgi, P.J. Pockros,
C. Wang, G. Decosterd, P. Grosgurin , H. Porchet, R. Crabbe
![debio-1.gif](../images/043109/debio-1.gif)
![backGround-2.gif](../images/043109/backGround-2.gif)
![HCV-3.gif](../images/043109/HCV-3.gif)
![aims-4.gif](../images/043109/aims-4.gif)
![AgeMean-5.gif](../images/043109/AgeMean-5.gif)
![load-6.gif](../images/043109/load-6.gif)
![trough-7.gif](../images/043109/trough-7.gif)
![SD-8.gif](../images/043109/SD-8.gif)
![PegIfn-9.gif](../images/043109/PegIfn-9.gif)
![nWith-10.gif](../images/043109/nWith-10.gif)
![RBV-11.gif](../images/043109/RBV-11.gif)
![adverse-12.gif](../images/043109/adverse-12.gif)
![MRP-13.gif](../images/043109/MRP-13.gif)
![Treatmnt-14.gif](../images/043109/Treatmnt-14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|